Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP323407.RAdiqdwrKmNSrLdL5cNTNSQmoBAvQPPgeCmR0Bn1WKPB8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP323407.RAdiqdwrKmNSrLdL5cNTNSQmoBAvQPPgeCmR0Bn1WKPB8130_assertion type Assertion NP323407.RAdiqdwrKmNSrLdL5cNTNSQmoBAvQPPgeCmR0Bn1WKPB8130_head.
- NP323407.RAdiqdwrKmNSrLdL5cNTNSQmoBAvQPPgeCmR0Bn1WKPB8130_assertion description "[Therefore, we examined whether the transcriptional deregulation of RB/MDM2 pathway was responsible for DNMT3A overexpression and analyzed the therapeutic potential of MDM2 antagonist for reversing aberrant DNA methylation status in lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP323407.RAdiqdwrKmNSrLdL5cNTNSQmoBAvQPPgeCmR0Bn1WKPB8130_provenance.
- NP323407.RAdiqdwrKmNSrLdL5cNTNSQmoBAvQPPgeCmR0Bn1WKPB8130_assertion evidence source_evidence_literature NP323407.RAdiqdwrKmNSrLdL5cNTNSQmoBAvQPPgeCmR0Bn1WKPB8130_provenance.
- NP323407.RAdiqdwrKmNSrLdL5cNTNSQmoBAvQPPgeCmR0Bn1WKPB8130_assertion SIO_000772 22733537 NP323407.RAdiqdwrKmNSrLdL5cNTNSQmoBAvQPPgeCmR0Bn1WKPB8130_provenance.
- NP323407.RAdiqdwrKmNSrLdL5cNTNSQmoBAvQPPgeCmR0Bn1WKPB8130_assertion wasDerivedFrom befree-20140225 NP323407.RAdiqdwrKmNSrLdL5cNTNSQmoBAvQPPgeCmR0Bn1WKPB8130_provenance.
- NP323407.RAdiqdwrKmNSrLdL5cNTNSQmoBAvQPPgeCmR0Bn1WKPB8130_assertion wasGeneratedBy ECO_0000203 NP323407.RAdiqdwrKmNSrLdL5cNTNSQmoBAvQPPgeCmR0Bn1WKPB8130_provenance.